| 2-AG |
2-arachidonoylglycerol |
| 5-HT |
5-hydroxytryptamine (serotonin) |
| 5-HT1A |
serotonin receptor 1A |
| 5-HT2B |
serotonin receptor 2B |
| 5-HT3 |
serotonin receptor 3 |
|
9-THC |
9-tetrahydrocannabinol |
| AA |
arachidonic acid |
| ABHD6 |
/ hydrolase domain 6 |
| ABHD12 |
/ hydrolase domain 12 |
| AC |
adenylyl cyclase |
| ACE |
angiotensin-converting enzyme |
| AD |
Alzheimer disease |
| AEA |
N-arachidonoylethanolamine (anandamide) |
| AIDS |
acquired immunodeficiency syndrome |
| ALS |
amyotrophic lateral sclerosis |
| AM404 |
N-arachidonoylaminophenol |
| AMP |
adenosine monophosphate |
| AMPA |
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| AMPK |
AMP-activated protein kinase |
| AMT |
anandamide membrane transporter |
| BLA |
basolateral complex of amygdala |
| BP |
blood pressure |
| cAMP |
cyclic adenosine monophosphate |
| CB |
cannabinoid |
| CB1 |
cannabinoid receptor type 1 |
| CB2 |
cannabinoid receptor type 2 |
| CBD |
cannabidiol |
| CBDV |
cannabidivarin |
| CBR |
cannabinoid receptor |
| CIPN |
chemotherapy-induced peripheral neuropathy |
| CNS |
central nervous system |
| COX |
cyclooxygenase |
| COX-2 |
cyclooxygenase 2 |
| COX-3 |
cyclooxygenase 3 |
| CXCR4 |
C-X-C chemokine receptor type 4 |
| DA |
dopamine |
| DAG |
diacylglycerol |
| DAGL |
diacylglycerol lipase |
| DN |
diabetic neuropathy |
| DPP4 |
dipeptidyl peptidase 4 |
| eCB |
endocannabinoid |
| ECS |
endocannabinoid system |
| ER |
endoplasmic reticulum |
| ET |
endotoxin tolerance |
| FAAH |
fatty acid amide hydrolase |
| FABP |
fatty-acid-binding protein |
| FCD |
focal cortical dysplasia |
| FDA |
Food and Drug Administration |
| GABA |
-aminobutyric acid |
| GDP |
guanosine diphosphate |
| GI |
gastrointestinal |
| GIT |
gastrointestinal tract |
| GLUT-2 |
glucose transporter 2 |
| GPCR |
G protein-coupled receptor |
| GPR18 |
G protein-coupled receptor 18 |
| GPR55 |
G protein-coupled receptor 55 |
| GPR119 |
G protein-coupled receptor 119 |
| GTP |
guanosine triphosphate |
| HAND |
human immunodeficiency virus associated neurocognitive disorder |
| HER2 |
human epidermal growth factor receptor 2 |
| HIV-1 |
human immunodeficiency virus 1 |
| HPA |
hypothalamic-pituitary-adrenal axis |
| HPO |
hypothalamic-pituitary-ovarian axis |
| HSP70 |
70 kilodalton heat shock protein |
| IBD |
inflammatory bowel disease |
| IL-1
|
interleukin 1
|
| IL-6 |
interleukin 6 |
| IL-18 |
interleukin 18 |
| IMMA |
indomethacin morpholinamide |
| iNOS |
inducible nitric oxide synthase |
| IPAH |
idiopathic pulmonary arterial hypertension |
| LHb |
lateral habenula |
| LPI |
lysophosphatidylinositol |
| LPS |
lipopolysaccharide (endotoxin) |
| MAGL |
monoacylglycerol lipase |
| MAPK |
mitogen activated protein kinase |
| MCP-1 |
monocyte chemoattractant protein 1 |
| MI |
myocardial infraction |
| MOA |
mechanism of action |
| mTORC1 |
mammalian target of rapamycin complex 1 |
| NAAA |
N-acylethanolamine acid amidase |
| NAFLD |
nonalcoholic fatty liver disease |
| NAM |
negative allosteric modulator |
| NAPE |
N-acylphosphatidylethanolamine |
| NAPE-PLD |
N-acylphosphatidylethanolamine-hydrolyzing phospholipase D |
| NASH |
nonalcoholic steatohepatitis |
| NF-B |
nuclear factor-B |
| NMDA |
N-methyl-D-aspartate |
| NOS |
nitric oxide synthase |
| NSAID |
nonsteroidal anti-inflammatory drug |
| NSC |
neural stem cell |
| OEA |
oleoylethanolamine |
| OXPKOS |
oxidative phosphorylation |
| PAM |
positive allosteric modulator |
| PEA |
palmitoylethanolamide |
| PG |
prostaglandin |
| PGE2 |
prostaglandin E2
|
| PPAR |
peroxisome proliferator-activated receptor |
| PPAR
|
peroxisome proliferator-activated receptor
|
| PPAR
|
peroxisome proliferator-activated receptor
|
| PRCB |
peripherally restricted cannabinoid |
| PTSD |
post-traumatic stress disorder |
| RNA |
ribonucleic acid |
| ROS |
reactive oxygen species |
| SCA |
spinocerebellar ataxia |
| SSc |
systemic sclerosis |
| T2DM |
type 2 diabetes mellitus |
| TBI |
traumatic brain injury |
| THC |
tetrahydrocannabinol |
| TIMP-1 |
tissue inhibitor of matrix metalloproteinases-1 |
| TLR3 |
toll-like receptor 3 |
| TLR4 |
toll-like receptor 4 |
| TNF |
tumor necrosis factor |
| TNF-
|
tumor necrosis factor
|
| TRPV1 |
transient receptor potential vanilloid type 1 channel |
| WAT |
white adipose tissue |